InnovAge Holding Corp

Análisis de la acción InnovAge Holding Corp (INNV)

$8.880

+0.030 (+0.34%)Al cierre

Loading chart…
Máximo
8.960
Apertura
8.880
Precio medio ponderado por volumen
8.88
Volumen
288.78K
Capitalización
712.58M
Mínimo
8.810
Importe
2.57M
EV/EBITDA, TTM
15.09

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

www.innovage.com

Análisis de IA of InnovAge Holding Corp (INNV)

Mantener

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.

Métricas de valoración

El PER previsto actual de InnovAge Holding Corp (INNV) es 13.66, frente a su media de 5 años de -108.19.

PER previsto

Valor razonable
Media 5A P/E
-108.19
P/E actual
13.66
Sobrevalorada
968.96
Infravalorada
-1185.33

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-7.89
EV/EBITDA actual
15.09
Sobrevalorada
181.43
Infravalorada
-197.22

Precio/ventas previsto

Valor razonable
Media 5A P/S
0.98
P/S actual
1.04
Sobrevalorada
1.27
Infravalorada
0.69

Escenarios de precio de Alphio AI para INNV

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%INNV

$4.78

Precio del escenario

B

Base

Base · 50%INNV

$4.75

Precio del escenario

B

Bajista

Bajista · 25%INNV

$3.97

Precio del escenario

Ballenas con INNV en cartera

C

Coliseum Capital Management, LLC

+ Con en carteraINNV

-26.24%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-23 (ET)

16:30:00

Major Averages Close Lower as 10-Year Treasury Yield Hits 5.13%

12:00:00

Major Averages Broadly Lower as Oil Rises Over 1%

2026-09-22 (ET)

22:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering Priced at $9.25

20:00:00

Dow Falls, Nasdaq Hits New Record Highs

17:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering

Noticias

Preguntas frecuentes sobre INNV, respondidas por Alphio AI

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar